The global organ preservation market is projected to reach USD 0.3 billion by 2030 from USD 0.2 million in 2025, at a CAGR of 6.8% during the forecast period.
The primary objective of organ preservation solutions and devices is to maintain the viability and functionality of organs between procurement and transplantation. Several factors fuel consistent growth in this market, including the increasing volume of organ transplants globally, technological advancements in preservation techniques, and the introduction of specialized solutions such as hypothermic and normothermic machine perfusion systems. The growing incidence of chronic diseases such as end-stage renal and liver failure is driving the demand for organ transplants, which in turn boosts the need for effective preservation technologies.
By solution type, the University of Wisconsin (UW) segment accounted for the largest market share in 2024.
The market is categorized into UW, Custodiol HTK, Perfadex, and other solutions by solution type. In 2024, the University of Wisconsin (UW) solution accounted for the largest market share owing to high adoption and features such as proven efficacy in preserving organs like the liver, kidneys, and pancreas. It was the first introduced intracellular preservation solution and is widely regarded as the global benchmark for organ preservation. Its established clinical outcomes and reliability have solidified its position as the preferred choice among transplant surgeons and healthcare facilities.
By technique, the normothermic machine perfusion segment is expected to register the highest CAGR during the forecast period.
The normothermic machine perfusion segment is expected to grow at the highest CAGR during the forecast period. This technique simulates natural physiological conditions by maintaining normal body temperature and supplying essential nutrients and oxygen to the organ. It supports cellular function and metabolism throughout the preservation period. Normothermic perfusion helps maintain organ viability and minimizes inflammatory responses and ischemic injury, particularly in liver transplants. It is vital in improving graft regeneration and has been associated with better outcomes in transplant cases involving extended criteria donors, such as older individuals or those with comorbidities. As a result, its relevance is growing among transplant professionals seeking to optimize long-term graft survival and function.
By organ type, the lungs segment is expected to grow at the highest CAGR during the forecast period.
The lungs segment is expected to grow at the highest CAGR during the forecast period. Lung transplantation is regarded as the preferred treatment for patients with end-stage lung diseases such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, or cystic fibrosis, all of which contribute to the growth of this segment. Other common causes of end-stage lung disease in adult patients include alpha-1 antitrypsin deficiency and pulmonary hypertension. With the increasing prevalence of respiratory illnesses, the number of patients requiring lung transplants is anticipated to rise, thereby driving demand for lung transplants. Additionally, advancements in graft survival and long-term graft function have established lung transplantation as a vital and often life-saving therapeutic option.
By end user, the specialty clinics segment is expected to grow at the highest CAGR during the forecast period.
The organ preservation market is segmented by end-users into organ transplant centers, hospitals, and specialty clinics. The specialty clinics segment is projected to grow at the highest CAGR in the organ preservation market due to their increasing role in transplant procedures and post-operative care. These clinics offer focused expertise, faster turnaround times, and advanced technologies tailored to organ preservation needs. Additionally, growing patient preference for specialized care and the rise in private healthcare investments further accelerate their growth in this segment.
By region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.
The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is primarily attributed to the combination of favorable government policies, increased public awareness, and a higher number of organ donations. For instance, China has seen its donation rates improve thanks to intensified public education, mobilization efforts, and technological advancements in organ transplants. Meanwhile, India's rapid development in healthcare infrastructure has supported market growth and fostered medical tourism. Even with religious considerations, Japan has observed an improvement in organ donation due to a higher willingness to donate organs.
The breakdown of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, the Middle East & Africa–1%, and GCC countries—1%
Key Players in the Organ Preservation Market
The key players operating in the organ preservation market include Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).
Research Coverage:
The report analyzes the organ preservation market and aims to estimate the market size and future growth potential based on various segments such as solution, technique, organ type, end user, and region. The report also includes a product portfolio matrix of various organ preservation products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which in turn would help them garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Analysis of key drivers (Ascending cases of multiple organ failure and growth in the geriatric population, the increasing initiatives to promote public awareness and encourage organ donation, the rising number of organ donors boost adoption of solid organ transplantation procedures); restraints (High cost of organ transplantation and religious concerns and misconceptions associated to organ donation); opportunities (the increasing focus on healthcare investments); and challenges (Significant gap between the number of organs donated and organs required annually coupled with the development of artificial organs)
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global organ preservation market. The report analyzes this market by solution, technique, organ type, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global organ preservation market
• Market Development: Comprehensive information on the lucrative emerging markets by solution type, technique, organ type, and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global organ preservation market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global organ preservation market.
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024 26
TABLE 2 GROWTH IN GERIATRIC POPULATION (ABOVE 65 AGE GROUP), BY REGION,
2019 VS. 2050 (MILLION) 52
TABLE 3 NUMBER OF ORGAN DONATIONS, 2020 54
TABLE 4 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 55
TABLE 5 AVERAGE SELLING PRICE RANGE OF ORGAN PRESERVATION SOLUTIONS,
BY KEY PLAYERS, 2023–2024 58
TABLE 6 AVERAGE SELLING PRICE RANGE OF CUSTODIOL SOLUTIONS FOR ORGAN PRESERVATION SOLUTIONS IN KEY REGIONS, 2022–2024 59
TABLE 7 ORGAN PRESERVATION MARKET: LIST OF MAJOR PATENTS, 2020–2021 62
TABLE 8 IMPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 65
TABLE 9 EXPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 65
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS (%) 72
TABLE 15 KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS 73
TABLE 16 CASE STUDY 1: PRESERVATION OF MARGINAL LIVER USING NORMOTHERMIC MACHINE PERFUSION (NMP) 74
TABLE 17 CASE STUDY 2: HYPOTHERMIC MACHINE PERFUSION FOR EXTENDED CRITERIA KIDNEY TRANSPLANT 74
TABLE 18 CASE STUDY 3: USE OF PORTABLE NORMOTHERMIC PERFUSION FOR HEART TRANSPLANTATION 75
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 20 ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION) 82
TABLE 21 ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 83
TABLE 22 ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 84
TABLE 23 ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 86
TABLE 24 ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 87
TABLE 25 OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 88
TABLE 26 COMPARISON OF METHODS USED FOR ORGAN PRESERVATION 90
TABLE 27 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 90
TABLE 28 ORGAN PRESERVATION TECHNIQUE MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 91
TABLE 29 STATIC COLD STORAGE: ADVANTAGES AND DISADVANTAGES 92
TABLE 30 ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 93
TABLE 31 HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES 94
TABLE 32 ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 95
TABLE 33 NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES 96
TABLE 34 ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 97
TABLE 35 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION) 99
TABLE 36 KIDNEY PRESERVATION MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 100
TABLE 37 LIVER PRESERVATION MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 101
TABLE 38 LUNG PRESERVATION MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 103
TABLE 39 HEART PRESERVATION MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 104
TABLE 40 OTHER ORGAN PRESERVATION MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 105
TABLE 41 ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION) 107
TABLE 42 ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 108
TABLE 43 ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 109
TABLE 44 ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 110
TABLE 45 ORGAN PRESERVATION MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 46 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 47 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 115
TABLE 48 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 115
TABLE 49 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 116
TABLE 50 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 116
TABLE 51 US: KEY MACROINDICATORS 117
TABLE 52 WAITING LIST FOR ORGAN TRANSPLANTS AS OF JANUARY 2022 117
TABLE 53 US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 118
TABLE 54 US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION) 118
TABLE 55 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION) 119
TABLE 56 US: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION) 119
TABLE 57 CANADA: KEY MACROINDICATORS 120
TABLE 58 CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 120
TABLE 59 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 121
TABLE 60 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 121
TABLE 61 CANADA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 121
TABLE 62 EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 63 EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 123
TABLE 64 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 124
TABLE 65 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 124
TABLE 66 EUROPE: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 125
TABLE 67 GERMANY: KEY MACROINDICATORS 126
TABLE 68 GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 126
TABLE 69 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 126
TABLE 70 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 127
TABLE 71 GERMANY: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 127
TABLE 72 FRANCE: KEY MACROINDICATORS 128
TABLE 73 FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 128
TABLE 74 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 128
TABLE 75 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 129
TABLE 76 FRANCE: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 129
TABLE 77 UK: KEY MACROINDICATORS 130
TABLE 78 TOTAL NUMBER OF PATIENTS ON ACTIVE ORGAN TRANSPLANT WAITING LIST IN
UK (AS OF APRIL 8, 2021) 130
TABLE 79 UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 130
TABLE 80 UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION) 131
TABLE 81 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION) 131
TABLE 82 UK: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION) 131
TABLE 83 SPAIN: KEY MACROINDICATORS 132
TABLE 84 SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 132
TABLE 85 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 133
TABLE 86 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 133
TABLE 87 SPAIN: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 134
TABLE 88 ITALY: KEY MACROINDICATORS 134
TABLE 89 ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 135
TABLE 90 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION) 135
TABLE 91 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 136
TABLE 92 ITALY: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 136
TABLE 93 REST OF EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 137
TABLE 94 REST OF EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 137
TABLE 95 REST OF EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 138
TABLE 96 REST OF EUROPE: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 138
TABLE 97 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 98 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 141
TABLE 99 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 142
TABLE 100 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 142
TABLE 101 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 143
TABLE 102 CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 144
TABLE 103 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 144
TABLE 104 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 145
TABLE 105 CHINA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 145
TABLE 106 TOTAL NUMBER OF PATIENTS ON ORGAN TRANSPLANT WAITING LIST IN JAPAN (AS OF MARCH 31, 2021) 146
TABLE 107 JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 146
TABLE 108 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 147
TABLE 109 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 147
TABLE 110 JAPAN: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 148
TABLE 111 INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 149
TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION) 149
TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 150
TABLE 114 INDIA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 115 AUSTRALIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 151
TABLE 116 AUSTRALIA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 151
TABLE 117 AUSTRALIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 152
TABLE 118 AUSTRALIA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 119 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 153
TABLE 120 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 153
TABLE 121 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 154
TABLE 122 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 123 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 155
TABLE 124 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 155
TABLE 125 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 156
TABLE 126 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 127 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 157
TABLE 128 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 158
TABLE 129 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 158
TABLE 130 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 159
TABLE 131 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 159
TABLE 132 BRAZIL: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 160
TABLE 133 BRAZIL: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 160
TABLE 134 BRAZIL: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 161
TABLE 135 BRAZIL: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 161
TABLE 136 MEXICO: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 162
TABLE 137 MEXICO: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 162
TABLE 138 MEXICO: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 163
TABLE 139 MEXICO: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 163
TABLE 140 REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 164
TABLE 141 REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 164
TABLE 142 REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION) 165
TABLE 143 REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 144 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 166
TABLE 145 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 167
TABLE 146 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION) 167
TABLE 147 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 168
TABLE 148 GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 169
TABLE 149 GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY SOLUTION,
2023–2030 (USD MILLION) 170
TABLE 150 GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY ORGAN TYPE,
2023–2030 (USD MILLION) 170
TABLE 151 GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY END USER,
2023–2030 (USD MILLION) 171
TABLE 152 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORGAN PRESERVATION MARKET 173
TABLE 153 ORGAN PRESERVATION MARKET: DEGREE OF COMPETITION 176
TABLE 154 ORGAN PRESERVATION MARKET: SOLUTION FOOTPRINT 180
TABLE 155 ORGAN PRESERVATION MARKET: TECHNIQUE FOOTPRINT 181
TABLE 156 ORGAN PRESERVATION MARKET: END USER FOOTPRINT 182
TABLE 157 ORGAN PRESERVATION MARKET: REGION FOOTPRINT 183
TABLE 158 ORGAN PRESERVATION MARKET: LIST OF KEY STARTUPS/SMES 185
TABLE 159 ORGAN PRESERVATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 186
TABLE 160 ORGAN PRESERVATION MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JUNE 2025 188
TABLE 161 ORGAN PRESERVATION MARKET: DEALS, JANUARY 2021–JUNE 2025 189
TABLE 162 ORGAN PRESERVATION MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–JUNE 2025 190
TABLE 163 PARAGONIX TECHNOLOGIES, INC.: COMPANY OVERVIEW 191
TABLE 164 PARAGONIX TECHNOLOGIES, INC.: PRODUCTS OFFERED 191
TABLE 165 PARAGONIX TECHNOLOGIES, INC.: PRODUCT LAUNCHES,
JANUARY 2021–MAY 2025 192
TABLE 166 PARAGONIX TECHNOLOGIES, INC.: DEALS, JANUARY 2021–MAY 2025 193
TABLE 167 PARAGONIX TECHNOLOGIES, INC.: OTHER DEVELOPMENTS,
JANUARY 2021–MAY 2025 194
TABLE 168 XVIVO PERFUSION AB: COMPANY OVERVIEW 196
TABLE 169 XVIVO PERFUSION AB: PRODUCTS OFFERED 197
TABLE 170 XVIVO PERFUSION AB: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–MAY 2025 198
TABLE 171 XVIVO PERFUSION AB: DEALS, JANUARY 2021–MAY 2025 199
TABLE 172 DR. FRANZ KÖHLER CHEMIE GMBH: COMPANY OVERVIEW 201
TABLE 173 DR. FRANZ KÖHLER CHEMIE GMBH: PRODUCTS OFFERED 201
TABLE 174 ESSENTIAL PHARMACEUTICALS, LLC: COMPANY OVERVIEW 203
TABLE 175 ESSENTIAL PHARMACEUTICALS, LLC: PRODUCTS OFFERED 203
TABLE 176 TRANSMEDICS, INC.: COMPANY OVERVIEW 205
TABLE 177 TRANSMEDICS, INC.: PRODUCTS OFFERED 206
TABLE 178 TRANSMEDICS, INC.: PRODUCT LAUNCHES & APPROVALS 206
TABLE 179 TRANSMEDICS, INC.: DEALS 206
TABLE 180 ORGANOX LIMITED: COMPANY OVERVIEW 208
TABLE 181 ORGANOX LIMITED: PRODUCTS OFFERED 208
TABLE 182 ORGANOX LIMITED: PRODUCT LAUNCHES & APPROVALS 208
TABLE 183 ORGANOX LIMITED: DEALS 209
TABLE 184 21ST CENTURY MEDICINE: COMPANY OVERVIEW 210
TABLE 185 21ST CENTURY MEDICINE: PRODUCTS OFFERED 210
TABLE 186 BIOLIFE SOLUTIONS, INC.: COMPANY OVERVIEW 211
TABLE 187 BIOLIFE SOLUTIONS, INC.: PRODUCTS OFFERED 212
TABLE 188 BIOLIFE SOLUTIONS, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 212
TABLE 189 BIOLIFE SOLUTIONS, INC.: DEALS, JANUARY 2021–MAY 2025 213
TABLE 190 BRIDGE TO LIFE LIMITED: COMPANY OVERVIEW 214
TABLE 191 BRIDGE TO LIFE LIMITED: PRODUCTS OFFERED 214
TABLE 192 BRIDGE TO LIFE LIMITED: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–MAY 2025 215
TABLE 193 BRIDGE TO LIFE LIMITED: DEALS, JANUARY 2021–MAY 2025 215
TABLE 194 WATERS MEDICAL SYSTEMS LLC: COMPANY OVERVIEW 216
TABLE 195 WATERS MEDICAL SYSTEMS LLC: PRODUCTS OFFERED 216
FIGURE 1 ORGAN PRESERVATION MARKET: RESEARCH DESIGN 28
FIGURE 2 LIST OF PRIMARY SOURCES 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: XVIVO PERFUSION AB (2024) 36
FIGURE 8 ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION 37
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET (2024) 38
FIGURE 10 TOP-DOWN APPROACH 38
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGAN PRESERVATION MARKET (2025–2030) 39
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 13 DATA TRIANGULATION METHODOLOGY 41
FIGURE 14 ORGAN PRESERVATION MARKET, BY SOLUTION, 2025 VS. 2030 (USD MILLION) 43
FIGURE 15 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 16 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 17 ORGAN PRESERVATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 45
FIGURE 18 GEOGRAPHIC ANALYSIS OF ORGAN PRESERVATION MARKET 46
FIGURE 19 RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE ORGAN PRESERVATION MARKET 47
FIGURE 20 UNIVERSITY OF WISCONSIN SOLUTION AND CHINA SEGMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ORGAN PRESERVATION MARKET IN 2024 48
FIGURE 21 CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 49
FIGURE 22 NORTH AMERICA TO DOMINATE ORGAN PRESERVATION MARKET TILL 2030 49
FIGURE 23 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 50
FIGURE 24 ORGAN PRESERVATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 51
FIGURE 25 ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 26 ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS 58
FIGURE 27 SUPPLY CHAIN ANALYSIS: ORGAN PRESERVATION MARKET (2024) 59
FIGURE 28 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ORGAN PRESERVATION SOLUTIONS (JANUARY 2014–APRIL 2025) 61
FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ORGAN PRESERVATION PATENTS, 2014–2025 61
FIGURE 30 ORGAN PRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS 70
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS 72
FIGURE 32 KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS 72
FIGURE 33 TRENDS AND DISRUPTIONS DISRUPTING CUSTOMER BUSINESS IN ORGAN PRESERVATION MARKET 73
FIGURE 34 ORGAN PRESERVATION MARKET: INVESTMENT AND FUNDING SCENARIO,
2021–2024 75
FIGURE 35 ORGAN PRESERVATION MARKET: AI INTEGRATION 77
FIGURE 38 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT 140
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN ORGAN PRESERVATION MARKET (2021−2024) 175
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS (2024) 175
FIGURE 41 ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 178
FIGURE 42 ORGAN PRESERVATION MARKET: COMPANY FOOTPRINT 179
FIGURE 43 ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 185
FIGURE 44 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF
KEY VENDORS 186
FIGURE 45 EV/EBITDA OF KEY VENDORS 187
FIGURE 46 ORGAN PRESERVATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 187
FIGURE 47 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2024) 197
FIGURE 48 TRANSMEDICS, INC.: COMPANY SNAPSHOT (2024) 205
FIGURE 49 BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2024) 211
FIGURE 1 ORGAN PRESERVATION MARKET: RESEARCH DESIGN 28
FIGURE 2 LIST OF PRIMARY SOURCES 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: XVIVO PERFUSION AB (2024) 36
FIGURE 8 ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION 37
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET (2024) 38
FIGURE 10 TOP-DOWN APPROACH 38
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGAN PRESERVATION MARKET (2025–2030) 39
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 13 DATA TRIANGULATION METHODOLOGY 41
FIGURE 14 ORGAN PRESERVATION MARKET, BY SOLUTION, 2025 VS. 2030 (USD MILLION) 43
FIGURE 15 ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 16 ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 17 ORGAN PRESERVATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 45
FIGURE 18 GEOGRAPHIC ANALYSIS OF ORGAN PRESERVATION MARKET 46
FIGURE 19 RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE ORGAN PRESERVATION MARKET 47
FIGURE 20 UNIVERSITY OF WISCONSIN SOLUTION AND CHINA SEGMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ORGAN PRESERVATION MARKET IN 2024 48
FIGURE 21 CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 49
FIGURE 22 NORTH AMERICA TO DOMINATE ORGAN PRESERVATION MARKET TILL 2030 49
FIGURE 23 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 50
FIGURE 24 ORGAN PRESERVATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 51
FIGURE 25 ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 26 ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS 58
FIGURE 27 SUPPLY CHAIN ANALYSIS: ORGAN PRESERVATION MARKET (2024) 59
FIGURE 28 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ORGAN PRESERVATION SOLUTIONS (JANUARY 2014–APRIL 2025) 61
FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ORGAN PRESERVATION PATENTS, 2014–2025 61
FIGURE 30 ORGAN PRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS 70
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS 72
FIGURE 32 KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS 72
FIGURE 33 TRENDS AND DISRUPTIONS DISRUPTING CUSTOMER BUSINESS IN ORGAN PRESERVATION MARKET 73
FIGURE 34 ORGAN PRESERVATION MARKET: INVESTMENT AND FUNDING SCENARIO,
2021–2024 75
FIGURE 35 ORGAN PRESERVATION MARKET: AI INTEGRATION 77
FIGURE 38 ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT 140
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN ORGAN PRESERVATION MARKET (2021−2024) 175
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS (2024) 175
FIGURE 41 ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 178
FIGURE 42 ORGAN PRESERVATION MARKET: COMPANY FOOTPRINT 179
FIGURE 43 ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 185
FIGURE 44 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF
KEY VENDORS 186
FIGURE 45 EV/EBITDA OF KEY VENDORS 187
FIGURE 46 ORGAN PRESERVATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 187
FIGURE 47 XVIVO PERFUSION AB: COMPANY SNAPSHOT (2024) 197
FIGURE 48 TRANSMEDICS, INC.: COMPANY SNAPSHOT (2024) 205
FIGURE 49 BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2024) 211